Article
Activating <i>RET</i> Mutations Promotes Osteoblastic Bone Metastases in Medullary Thyroid Cancer
2025-07-14
Abstract excerpt
<h4>Summary</h4> Development of bone metastases increases mortality in patients with medullary thyroid cancer (MTC), with ∼50% survival at 5 years after diagnosis, but the underlying mechanisms are unknown. We show that patient-derived MTC cells ( RET C634W mutant TT cells and RET M918T mutant MZCRC1 cells) promote an osteoblastic phenotype due to reduced bone resorption. Mechanistically, activated RET increase...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 71a1ffb0-3c44-5543-9d70-63ba7cd75715
- DOI
- 10.1101/2025.07.09.663851
